Island-specific differences in exposure to chronic disease risk factors Study participants were drawn equally from Waiben, the main commercial and administrative center of the Torres Strait Islands (n = 50), and Mer, a smaller, more remote, island (n = 50). There were no island differences in participant gender (males: n = 27 in Waiben, n = 24 in Mer, p=0.548) or in the prevalence of current smokers (smokers: n = 17 in Waiben, n = 16 in Mer, p=0.832). Residents of Mer largely consumed a diet that is traditional in the Torres Strait Islands (Niccoli and Partridge, 2012), including frequent consumption of fresh seafood. In comparison, Waiben residents had a more ‘westernized’ diet, characterized by significantly higher consumption of takeaway food and alcohol, and lower consumption of seafood (Table 1). Although current dogma suggests such dietary habits would be associated with increased chronic disease risk, increased levels of chronic disease risk markers were not observed for Waiben residents. Specifically, Mer residents had significantly (p<0.05) greater systolic blood pressure, mean arterial pressure (MAP), C-reactive protein, IL-12, IL-18, and IFNγ, compared to Waiben residents. While not achieving statistical significance (p=0.100), the prevalence of T2D in Mer residents was also greater than in Waiben residents (48% versus 30%, respectively; Table 1). Table 1. Characteristics of Waiben and Mer residents. Characteristic Waiben (n = 50) Mer (n = 50) Unadjusted P-value * Age-adjusted P-value † Age [years] 40 (31, 54) 58 (36, 65) 0.003 NA Exposure chronic disease risk factors Sugar-sweetened beverage consumption [serves/day] 1 (0, 1) 1 (0, 1) 0.576 0.562 Fruit consumption [serves/day] 2 (1, 3) 2 (1, 2) 0.680 0.682 Vegetable consumption [serves/day] 3.5 (2.0, 5.0) 3.5 (2.0, 4.0) 0.609 0.606 Takeaway consumption [serves/week] 1 (0, 2) 0 (0, 1) 0.011 0.009 Seafood consumption [serves/week] 2 (1, 3) 2 (1, 5) 0.020 0.021 Alcoholic beverage consumption [serves/day] 0.33 (0.00, 0.99) 0.20 (0.00, 1.88) 0.597 0.592 Smoking [cigarettes/day] 0.00 (0.00, 5.25) 0.00 (0.00, 2.25) 0.804 0.800 Physical activity [min/week] 180 (90, 236) 210 (150, 360) 0.925 0.925 Biological chronic disease risk factors Glucose [mmol/L] ‡ 5.2 (4.7, 5.7) 5.6 (4.8, 6.5) 0.056 0.050 HbA1c [mmol/mol] ‡ 38 (34, 42) 43 (36.5, 45) 0.127 0.109 Systolic blood pressure [mmHg] 121 (112.5, 129.5) 129 (115.3, 139.5) 0.028 0.025 Mean arterial pressure [mmHg] 87.8 (72.0–113.7) 95.8 (61.0–126.3) 0.034 0.033 Body mass index [kg/m2] 31.1 (25.8, 37.9) 32.1 (25.5, 36.5) 0.893 0.893 Waist circumference [cm] 105 (92, 116) 116 (101, 125) 0.019 0.016 Waist to hip ratio 0.62 (0.53, 0.69) 0.68 (0.61, 0.75) 0.035 0.027 Inflammatory biomarkers ‡ Interferon γ [pg/mL] 0.69 (0.61, 0.83) 0.96 (0.67, 1.18) <0.001 <0.001 C-Reactive protein [mg/L] 0.36 (0.23, 0.51) 1.36 (0.63, 1.76) <0.001 <0.001 Interleukin-1β [pg/mL] 0.39 (0.19, 0.61) 0.37 (0.23, 0.5) 0.534 0.536 Interleukin-12p40 [pg/mL] 1.98 (1.26, 3.47) 6.32 (3.31, 11.37) <0.001 <0.001 Interleukin-12p70 [pg/mL] 0.46 (0.41, 0.51) 0.82 (0.62, 1.07) <0.001 <0.001 Interleukin-13 [pg/mL] 1.72 (1.48, 1.94) 1.82 (1.82, 2.07) 0.008 0.008 Interleukin-15 [pg/mL] 7.37 (4.36, 10.7) 8.76 (6.89, 12.23) 0.281 0.272 Interleukin-18 [pg/mL] 11.34 (4.57, 18.17) 21.38 (13.26, 37.51) <0.001 <0.001 Interleukin-4 [pg/mL] 4.97 (4.61, 6.09) 6.80 (5.95, 9.23) <0.001 <0.001 MCP-1/CCL2 [pg/mL] 52.77 (32.89, 88.41) 111.60 (67.65, 149.9) <0.001 <0.001 Tumor necrosis factor α [pg/mL] 0.17 (0.11, 0.30) 0.47 (0.40, 0.68) <0.001 <0.001 Species-alpha diversity Count [Chao1 species richness] 68.5 (64.0, 72.3) 68.0 (57.8, 73.3) 0.805 0.805 Distribution [Shannon evenness index] 0.68 (0.61, 0.71) 0.71 (0.66, 0.75) 0.027 0.026 Variety [Shannon diversity index] 2.83 (2.50, 2.98) 2.94 (2.73, 3.20) 0.061 0.060 Results are median (Q1, Q3). * ANOVA between Mer and Waiben. † ANCOVA between Mer and Waiben adjusted for age. ‡ analysis performed on log-transformed data. Abbreviations: MCP: Monocyte Chemoattractant Protein; MIP: Macrophage Inflammatory Protein. The explanation for such a proatherogenic biomarker profile in Mer residents was not immediately apparent. Mer residents were significantly older than Waiben residents (mean age [years]: 41.5 versus 51.7; p=0.003), a recognized risk factor for chronic disease (Arumugam et al., 2011). However, significant differences in measures of blood pressure and inflammatory markers remained even after adjusting for age (Table 1).